ZMIZ2 promotes the development of triple-receptor negative breast cancer

Overview of attention for article published in Cancer Cell International, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,498 followers.

New updates are on our #breastcancer feed! “ZMIZ2 promotes the development of triple-receptor negative breast cancer,” from @BioMedCentral #bcsm https://t.co/GL5VCX7XaW Find more curated content every day on #Feedkast https://t.co/iu5jwPDphC

ZMIZ2 promotes the development of triple-receptor negative breast cancer https://t.co/zdI22wrEQH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.